0 items USD 0.00Search
Your search for "globaldata b cell chronic lymphocytic leukemia global clinical trials review h2 2018" gave back 677687 results.
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Leukemia Cancer market size was valued at US$ million in 2023. With growing demand in downstream market, the Leukemia Cancer is forecast...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Leukemia Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global CD20 Target Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Bruton's Tyrosine Kinase Inhibitors (BTKi), Bruton's TKI or BTKI, Ibrutinib, has shown great promise for B cell cancers with the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Leukemia Cancer Market The global Leukemia Cancer market is projected to grow from US$ million in 2023 to US$...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system. Market Analysis and Insights: Global Blood...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global BTK Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it is expected to grow at a...
Catalog:
LPI
June 2023
Price: USD 3,660.00
